High frequency stimulation of the subthalamic nucleus improves treadmill locomotion in unilateral 6-hydroxydopamine lesioned rats

Author(s): Chang JY, Shi LH, Luo F, Woodward DJ

Abstract

This study investigated the influence of electrical stimulation of the subthalamic nucleus (STN) on motor impairment induced by unilateral 6-hydroxydopamine (6-OHDA) lesions in the medial forebrain bundle. Rats were trained to walk on a treadmill and then implanted with microelectrode arrays in and near the STN. The neurotoxin 6-OHDA was injected into the medial forebrain bundle (MFB) unilaterally to produce a targeted lesion of the dopaminergic system. Successful lesions produced impaired treadmill walking behavior. High frequency stimulation (HFS) of the STN improved treadmill walking immediately and restored normal walking patterns. The same HFS failed to evoke visible side effects such as stepping, turning, raising of the head or facial muscle contraction in the absence of treadmill movement, or to change rotational behaviors elicited by the dopamine (DA) agonist apomorphine in unilateral lesioned rats. This suggests that the stimulation did not cause movement by an activation of brainstem locomotor regions or an increase attention leading to movement. Apomorphine-induced rotation may represent an imbalance of dopaminergic activation which remains during HFS. This work may provide a rodent model for deep brain stimulation (DBS) in patients with Parkinson's disease, and be suitable for further investigation of the neural mechanisms underlying the therapeutic effects of DBS.

Similar Articles

Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease

Author(s): Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL

Alterations of T-lymphocyte populations in Parkinson disease

Author(s): Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T

Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism

Author(s): Bas J, Calopa M, Mestre M, Molleví DG, Cutillas B, et al.

Apoptosis of peripheral blood lymphocytes in Parkinson patients

Author(s): Calopa M, Bas J, Callén A, Mestre M

The ABC of the blood-brain barrier - regulation of drug efflux pumps

Author(s): Mahringer A, Ott M, Reimold I, Reichel V, Fricker G

Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy

Author(s): van Vliet EA, da Costa Araújo S, Redeker S, van Schaik R, Aronica E, et al.

Blood-brain barrier disruption in multiple sclerosis

Author(s): Minagar A, Alexander JS

The role of neuroinflammation on the pathogenesis of Parkinson's disease

Author(s): Chung YC, Ko HW, Bok E, Park ES, Huh SH, et al.

Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA

Author(s): Bartels AL, Willemsen AT, Kortekaas R, de Jong BM, de Vries R, et al.

Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9

Author(s): Koronyo-Hamaoui M, Ko MK, Koronyo Y, Azoulay D, Seksenyan A, et al.

Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells

Author(s): Reynolds AD, Stone DK, Mosley RL, Gendelman HE

Leptin and ghrelin concentrations and weight loss in Parkinson's disease

Author(s): Fiszer U, Michałowska M, Baranowska B, Wolińska-Witort E, Jeske W, et al.

Innate and adaptive immunity for the pathobiology of Parkinson's disease

Author(s): Stone DK, Reynolds AD, Mosley RL, Gendelman HE

Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression

Author(s): Gruden MA, Sewell RD, Yanamandra K, Davidova TV, Kucheryanu VG, et al.

Anti-melanin antibodies are increased in sera in Parkinson's disease

Author(s): Double KL, Rowe DB, Carew-Jones FM, Hayes M, Chan DK, et al.

Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease

Author(s): Masliah E, Rockenstein E, Adame A, Alford M, Crews L, et al.

Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease

Author(s): Johnston LC, Su X, Maguire-Zeiss K, Horovitz K, Ankoudinova I, et al.

α-Synuclein and dopamine at the crossroads of Parkinson's disease

Author(s): Venda LL, Cragg SJ, Buchman VL, Wade-Martins R

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

Author(s): Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, et al.

T-cells in Alzheimer's disease

Author(s): Town T, Tan J, Flavell RA, Mullan M